Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together...

BLS Polymers IPO Allotment Status Check Online: Steps, GMP, and Key Details
PM Kisan 24th Installment Released: Check Payment Status and eKYC Rules
India vs Pakistan, Hong Kong Sixes 2026: Date, Venue, Live Streaming and TV Details
November news: 2026 horoscopes, a Nov 8 zodiac window, and a Nov 1 Delhi rally dispute
Suzlon Energy Share Price Crash: Q2 Revenue Up 26% to Rs 4,869 Crore, but Margins Disappoint 















